Systemic sclerosis-associated interstitial lung disease

Systemic sclerosis-associated interstitial lung disease is a severe pulmonary manifestation and the leading cause of mortality in patients diagnosed with systemic sclerosis, an autoimmune connective tissue disorder Clinically, affected individuals experience exertional dyspnea, nonproductive cough, and restrictive lung impairment on pulmonary function testing

Systemic sclerosis-associated interstitial lung disease is a severe pulmonary manifestation and the leading cause of mortality in patients diagnosed with systemic sclerosis, an autoimmune connective tissue disorder The condition primarily impacts the respiratory system and is characterized pathophysiologically by autoimmune-mediated inflammation, microvascular injury, and progressive extracellular matrix deposition leading to pulmonary fibrosis Clinically, affected individuals experience exertio...

Systemic sclerosis-associated interstitial lung disease is a severe pulmonary manifestation and the leading cause of mortality in patients diagnosed with systemic sclerosis, an autoimmune connective tissue disorder

The condition primarily impacts the respiratory system and is characterized pathophysiologically by autoimmune-mediated inflammation, microvascular injury, and progressive extracellular matrix deposition leading to pulmonary fibrosis High-resolution computed tomography typically demonstrates bilateral reticular opacities and ground-glass changes, predominantly manifesting as a nonspecific interstitial pneumonia pattern, which may progress to irreversible fibrosis and respiratory failure

The condition primarily impacts the respiratory system and is characterized pathophysiologically by autoimmune-mediated inflammation, microvascular injury, and progressive extracellular matrix deposition leading to pulmonary fibrosis